Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region

Key Facts

The global antidiabetics market size was estimated to be USD 100.01 billion in 2023 and is expected to reach USD 313.92 billion by 2034 with a CAGR of 10.96% during the forecast period 2024-2034.
Additionally, the SGLT-2 inhibitors segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising adoption of these drugs due to their efficacy in lowering blood glucose levels, favorable outcomes in cardiovascular and renal health, and increasing awareness among healthcare professionals and patients about the benefits of SGLT-2 inhibitors in the management of type 2 diabetes.
By application, the type 2 diabetes segment accounted for the highest revenue-grossing segment in the global antidiabetics market in 2023 owing to the escalating prevalence of type 2 diabetes worldwide, driven by factors such as sedentary lifestyles, unhealthy dietary habits, and an aging population, necessitating a substantial demand for a diverse range of oral antidiabetic drugs, injectables, and innovative treatment modalities tailored for the specific needs of individuals with type 2 diabetes.
Additionally, the type 1 diabetes segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing focus on advanced insulin therapies, technological innovations in insulin delivery systems, and a growing understanding of the unique needs of individuals with type 1 diabetes.